Recent Insider Activity Could Benefit Vor Biopharma Inc (VOR)

Vor Biopharma Inc’s recent filing unveils that its 10% Owner Reprogrammed Interchange LLC unloaded Company’s shares for reported $1.11 million on Sep 03 ’25. In the deal valued at $2.00 per share,554,612 shares were sold. As a result of this transaction, Reprogrammed Interchange LLC now holds 36,329,955 shares worth roughly $73.02 million.

Then, Reprogrammed Interchange LLC sold 453,016 shares, generating $873,641 in total proceeds. Upon selling the shares at $1.93, the 10% Owner now owns 35,876,939 shares.

Before that, Reprogrammed Interchange LLC sold 400,000 shares. Vor Biopharma Inc shares valued at $787,280 were divested by the 10% Owner at a price of $1.97 per share. As a result of the transaction, Reprogrammed Interchange LLC now holds 35,476,939 shares, worth roughly $71.31 million.

H.C. Wainwright upgraded its Vor Biopharma Inc [VOR] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. Goldman began covering VOR with “Neutral” recommendation on April 27, 2022. H.C. Wainwright started covering the stock on December 17, 2021. It rated VOR as “a Buy”.

Price Performance Review of VOR

On Tuesday, Vor Biopharma Inc [NASDAQ:VOR] saw its stock jump 1.52% to $2.01. Over the last five days, the stock has lost -1.47%. Vor Biopharma Inc shares have risen nearly 143.64% since the year began. Nevertheless, the stocks have risen 81.08% over the past one year. While a 52-week high of $3.29 was reached on 07/08/25, a 52-week low of $0.13 was recorded on 05/09/25.

Levels Of Support And Resistance For VOR Stock

The 24-hour chart illustrates a support level at 1.9800, which if violated will result in even more drops to 1.9400. On the upside, there is a resistance level at 2.0400. A further resistance level may holdings at 2.0600.

How much short interest is there in Vor Biopharma Inc?

A steep rise in short interest was recorded in Vor Biopharma Inc stocks on 2025-08-15, growing by 4.03 million shares to a total of 18.41 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 14.38 million shares. There was a rise of 21.89%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on December 03, 2021 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $38 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.